Dr. Chupp is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
789 Howard Ave
New Haven, CT 06519Phone+1 203-785-4198Fax+1 203-737-5453
Summary
- Dr. Geoffrey Chupp is a pulmonologist in New Haven, CT and is affiliated with multiple hospitals in the area, including Bridgeport Hospital and Yale-New Haven Hospital. He received his medical degree from George Washington University School of Medicine and has been in practice 27 years. He specializes in pleural disease.
Education & Training
- Boston University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1993 - 1997
- Tufts Medical CenterResidency, Internal Medicine, 1990 - 1993
- George Washington University School of Medicine and Health SciencesClass of 1990
Certifications & Licensure
- CT State Medical License 1997 - 2024
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Top MD Consumers Checkbook
Clinical Trials
- Camostat Mesylate in COVID-19 Outpatients Start of enrollment: 2020 Jun 09
Publications & Presentations
PubMed
- 93 citationsTransgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling.Chun Geun Lee, Hye Ryun Kang, Robert J. Homer, Geoffrey L. Chupp, Jack A. Elias
Proceedings of the American Thoracic Society. 2006-07-01 - 343 citationsRole of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13–induced tissue responses and apoptosisChun Geun Lee, Dominik Hartl, Gap Ryol Lee, Barbara Koller, Hiroshi Matsuura
The Journal of Experimental Medicine. 2009-05-11 - 381 citationsEffect of Variation in CHI3L1 on Serum YKL-40 Level, Risk of Asthma, and Lung FunctionCarole Ober, Zheng Tan, Ying Sun, Jennifer D. Possick, Lin Pan
The New England Journal of Medicine. 2008-04-17
Press Mentions
- 2023 ‘Top Doctors’ List Features Over 250 Yale Medicine PhysiciansMay 3rd, 2023
- Reducing Disparities in Asthma Prevalence in Black and Latino PeopleMay 13th, 2022
- Why the Covid Pandemic Was GOOD News for Many with AsthmaAugust 16th, 2021
- Join now to see all
Grant Support
- Gene Expression Profiling In Asthma Severity: CHI3L1 Genotypes And Serum YKL-40National Heart, Lung, And Blood Institute2008–2011
- Biology Of IL-16 In Il-1680 And Il-1614 Transgenic MiceNational Heart, Lung, And Blood Institute1999–2003
- Lymphocyte Chemoattractant Factor In SarcoidosisNational Heart, Lung, And Blood Institute1995
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: